When comparing these two methods, Pfeiffer et al (1998) have reported that significant correlation was found in the quantification of EGFR or Her-2 levels between ELISA and immunohistochemical methods studied in the lung and in breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.